This is a side effect some people experience when taking certain chemotherapy drugs. It causes redness, tingling, or pain on the palms of your hands and the soles of your feet.
Every report comes from a Lived member, sent anonymously.
Have you tried Moisturizers for Hand-Foot Syndrome?
Hand-foot syndrome is a skin reaction to certain cancer medicines that affects the palms of the hands and the soles of the feet. It often begins as tingling, warmth, dryness or redness, and can progress to swelling, a sunburn-like soreness, peeling, cracking or blisters. Its medical name, palmar-plantar erythrodysesthesia, simply means redness and abnormal sensation of the palms and soles. It matters for two reasons. When it becomes painful, it can make walking, gripping, cooking or typing difficult, and heavy peeling can temporarily wear away fingerprints, which may stop fingerprint locks on phones from working. It is also a common reason a cancer medicine's dose is paused or lowered. Hand-foot syndrome is not an allergy and not an infection, so it cannot spread to other people.
Hand-foot syndrome is caused by the cancer treatment itself, not by anything a person did. It is most closely linked with capecitabine (Xeloda), a chemotherapy pill used for several cancers including colorectal and breast cancer, and with liposomal doxorubicin, an intravenous chemotherapy packaged in tiny fat-based particles (different from standard doxorubicin). Fluorouracil (5-FU), cytarabine, gemcitabine and some other chemotherapy drugs can cause it too. Among people taking capecitabine alone after surgery for colon cancer, it is one of the most frequent side effects. The exact mechanism is not fully understood. One explanation is that pressure and friction from walking and gripping push small amounts of the drug out of tiny blood vessels near the skin surface, where it irritates the surrounding tissue. That helps explain why the palms and soles are affected most, and why heat, rubbing and pressure tend to make it worse. Risk rises with higher doses and some drug combinations, and it varies with age, sex and ethnic background. People who already have reduced feeling in their hands and feet, for example from diabetes, nerve damage (peripheral neuropathy) or poor circulation, are more likely to develop it. A related condition, hand-foot skin reaction, occurs with targeted cancer drugs that block the growth of new blood vessels, such as sorafenib, sunitinib and regorafenib. It tends to appear earlier in treatment, can be more severe, and concentrates on areas that take pressure or friction rather than spreading across the whole palm or sole, so care focuses on those spots.
There is no blood test or scan for hand-foot syndrome. A clinician recognizes it from the appearance of the hands and feet and its timing in relation to a medicine known to cause it. It builds over days to weeks rather than appearing within minutes or hours of a dose, which is one way it differs from an allergic reaction. Early changes often show up in the first few weeks of treatment; with capecitabine, the typical onset in clinical trials was about 2.6 months, ranging from 11 days to a year. The care team grades severity, because the grade guides what happens next. Grade 1 means skin changes such as redness or swelling without pain. Grade 2 means changes such as peeling, blisters, cracks or swelling that are painful and get in the way of everyday tasks like preparing meals or shopping. Grade 3 means severe changes with pain that limits basic self-care, such as bathing, dressing or getting to the toilet. Clinicians also check cracked or blistered skin for signs of infection.
The aim is to keep symptoms mild so the cancer treatment can continue as fully as possible. Skin care usually starts at the beginning of treatment: a thick, alcohol-free, fragrance-free moisturizer applied often, sometimes under cotton gloves or socks, and less heat, pressure and friction on the hands and feet. In practice that means avoiding hot water and hot tubs, wearing well-fitting cushioned shoes, and taking a break from long walks or runs, heavy gripping tasks, garden tools and pedicures. Cool packs can ease discomfort, and some guidelines recommend cooling the hands and feet during infusions of certain drugs. When symptoms appear, clinicians may add creams containing urea (a moisturizing ingredient that softens thickened skin) or corticosteroid creams to calm redness and burning, along with pain relief and sometimes steroid tablets. A dermatologist or podiatrist (foot specialist) can help with painful or thickened areas. For moderate or severe hand-foot syndrome, the most effective step is adjusting the cancer medicine. Guidelines generally recommend pausing it at grade 2 or 3 and restarting once the skin has improved, sometimes at a lower dose. This is a deliberate decision made with the oncology team, weighing comfort and function against the strength of cancer treatment. Some medicines may lower the chance of moderate or severe hand-foot syndrome, mainly in people taking capecitabine. In recent analyses pooling clinical trials, a diclofenac gel (an anti-inflammatory applied to the hands and feet) and celecoxib (an anti-inflammatory pill) both reduced grade 2 or worse symptoms, with diclofenac having the strongest overall support. Guidelines do not yet agree on these, and only some recommend celecoxib, so whether either makes sense depends on the treatment plan and a person's other health conditions.
Hand-foot syndrome often follows the rhythm of treatment, easing during breaks and returning when a medicine restarts. For many people it stays mild with consistent skin care. For others it builds over successive cycles, and the burden becomes practical: sore feet that make walking or standing at work difficult, tender fingertips that make buttons, typing or cooking harder, and reduced sensitivity to heat and cold that raises the risk of burns, falls and other injuries. Most people recover once their treatment is adjusted or finished, and the skin usually heals over the following weeks to months. Permanent loss of fingerprints is rare. Each treatment visit is a chance to review the skin, and keeping track of when symptoms start, how they change and what helps makes those conversations more useful. Reporting changes early gives the team more options, such as stronger skin treatment or a short pause, before the skin breaks down.
Mention any tingling, dryness or redness of your palms or soles to your cancer care team as soon as you notice it, even if it seems minor, so skin care can be stepped up early. Contact the team promptly, before your next dose, if your hands or feet become painful, peel, crack or blister, or if symptoms start to limit everyday tasks. If you take capecitabine tablets at home, its label says to stop taking them at that point and call your care team right away, rather than continuing until your next appointment. Call the team right away as well if a blister breaks open, if broken skin looks infected (worsening redness, swelling or pus), or if you develop a fever of 100.5°F (38°C) or higher, because chemotherapy can weaken the body's defenses against infection.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Hand-Foot Syndrome is like, what's helped you, or ask the community a question.